Ceapro Inc. operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Ceapro Inc. with three other
companies in this sector in Canada:
Neptune Technologies & Bioressources Inc
sales of 22.63 million Canadian Dollars [US$17.82 million]
Opiant Pharmaceuticals Inc
(13.09 million Canadian Dollars [US$10.31 million]
Microbix Biosystems Inc
(9.52 million Canadian Dollars [US$7.49 million]
During the year ended December of 2016, sales at
Ceapro Inc. were C$13.67 million (US$10.77 million).
increase of 28.2%
versus 2015, when the company's sales were C$10.67 million.
This was the fourth straight year of sales growth at Ceapro Inc..